C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2555989
Methods and kits are provided for determining whether a subject is at risk of developing a neurological disease such as Alzheimer's disease and multiple sclerosis. The methods and kits are based on the detection of one or more nucleic acid variants in the MBL gene of the subject.
Méthodes et kits permettant de déterminer si un sujet court le risque de contracter une maladie neurologique telle que la maladie d'Alzheimer ou la sclérose en plaques, ces méthodes et kits reposant sur la détection d'un ou de plusieurs variants d'acides nucléiques dans le gène MBL du sujet.
Nuytinck Lieve
Vanmechelen Eugeen
Abbott Healthcare Products B.v.
Innogenetics N.v.
Smart & Biggar
LandOfFree
Method for determining the risk of developing a neurological... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for determining the risk of developing a neurological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for determining the risk of developing a neurological... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1636661